Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24.71	124.33	65.4	193.99	295.18	243.14
Cash & Short-Term Investments	24.71	124.33	65.4	193.99	295.18	243.14
Cash Growth	-90.84%	90.10%	-66.29%	-34.28%	21.40%	48.08%
Accounts Receivable	6.99	16.85	-	1.34	-	51.38
Other Receivables	13.57	76.01	71.18	46.12	108.3	23.79
Receivables	20.56	92.87	71.18	47.46	108.3	75.17
Inventory	209.77	246.9	106.86	50.26	-	-
Prepaid Expenses	117.24	8.07	16.89	13	2.31	1.21
Other Current Assets	130.89	133.73	201.37	208.81	155.21	54.96
Total Current Assets	503.16	605.9	461.69	513.52	561.01	374.48
Property, Plant & Equipment	0.23	64.9	88.2	71.05	73.8	14.14
Goodwill	-	-	-	-	-	58.45
Long-Term Deferred Charges	188.99	167.69	99.67	102	49.67	4.08
Other Long-Term Assets	3.94	3.95	3.95	3.95	3.95	12.61
Total Assets	696.32	842.43	653.51	690.52	688.43	463.76
Accounts Payable	137.6	242.57	30.97	23.3	41.39	29.55
Accrued Expenses	77.89	41.19	140.89	66.48	65.76	41.22
Current Portion of Long-Term Debt	82.5	82.5	62.5	-	-	-
Current Portion of Leases	-	13.27	13.37	9.16	7.91	2.27
Current Unearned Revenue	-	147.26	75.41	136.06	95.39	115.96
Other Current Liabilities	114.97	11.15	3.42	1.56	9.22	0
Total Current Liabilities	412.96	537.94	326.56	236.57	219.67	188.99
Long-Term Debt	67.1	66.37	112.9	-	-	-
Long-Term Leases	-	29.58	42.71	29.06	36.48	4
Long-Term Unearned Revenue	-	-	-	-	0.54	8.26
Other Long-Term Liabilities	0	-0	0.01	-	-	4.81
Total Liabilities	480.06	633.89	482.17	265.63	256.69	206.06
Common Stock	343.5	343.5	6.68	6.17	5.61	4.98
Additional Paid-In Capital	1,395	1,395	1,429	1,294	1,134	773.72
Retained Earnings	-1,532	-1,540	-1,274	-885.83	-713.31	-524.94
Comprehensive Income & Other	10.09	10.23	10.12	10.32	5.16	3.95
Shareholders' Equity	216.26	208.54	171.34	424.89	431.74	257.71
Total Liabilities & Equity	696.32	842.43	653.51	690.52	688.43	463.76
Total Debt	149.6	191.72	231.48	38.22	44.38	6.26
Net Cash (Debt)	-124.89	-67.39	-166.08	155.77	250.8	236.88
Net Cash Growth	-	-	-	-37.89%	5.88%	53.06%
Net Cash Per Share	-0.08	-0.05	-5.79	6.09	10.63	13.08
Filing Date Shares Outstanding	1,532	1,529	29.81	27.51	25.04	22.2
Total Common Shares Outstanding	1,532	1,529	29.81	27.51	25.04	22.2
Working Capital	90.2	67.96	135.14	276.96	341.34	185.49
Book Value Per Share	0.14	0.14	5.75	15.45	17.24	11.61
Tangible Book Value	216.26	208.54	171.34	424.89	431.74	199.26
Tangible Book Value Per Share	0.14	0.14	5.75	15.45	17.24	8.98
Machinery	-	62.43	61.93	-	43.49	28.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.